Antithrombotic therapy in very elderly patients with atrial fibrillation: Is it enough to assess thromboembolic risk?

Although attention has been given to thromboprophylaxis for atrial fibrillation (AF) in present treatment guidelines, practical, clinical antithrombotic therapy is poorly developed for very elderly patients. We reviewed the records of 105 consecutive patients with AF of mean age 85 years, to determi...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yutao, Wu, Qiang, Zhang, Lu, Yang, Tingshu, Zhu, Ping, Gao, Wenqian, Zhao, Yuexiang, Gao, Meng
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877526/
https://www.ncbi.nlm.nih.gov/pubmed/20517485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877526/
https://www.ncbi.nlm.nih.gov/pubmed/20517485

Ejemplares similares